Search
Daclizumab
go.drugbank.com/drugs/DB00111ApprovedInvestigationalWithdrawnHumanized IgG1 Mab that binds to the human interleukin-2 receptor (anti-Tac or anti-CD25). Daclizumab is a composite of human (90%) and murine (10%) antibody sequences. … The murine sequences were derived from the complementarity-determining regions of a murine anti-Tac antibody.
Categories: Interleukin-2 Receptor Antagonist, Interleukin-2 Receptor Blocking AntibodyProducts: Zenapax 5mg/mlPidolic acid
go.drugbank.com/drugs/DB03088ApprovedInvestigationalPidolic acid is a naturally occurring but little-studied amino acid derivative that can be formed enzymatically or non-enzymatically and participates as a biological intermediate with unique pharmacodynamics … There are currently little to no medicines available that are clinically approved or marketed for employing pidolic acid as an active ingredient for any particular formal indication.
Mixtures: 2% Salicylic Acid FACIAL CLEANSERCategories: Heterocyclic Compounds, 1-RingInfertility
go.drugbank.com/conditions/DBCOND0019322Drugs: DydrogesteroneSynonyms: Cannot achieve a pregnancyPhenprobamate
go.drugbank.com/drugs/DB13354InvestigationalMixtures: KUIFLEX 200 MG/200 MG FİLM KAPLI TABLET, 40 ADET, KUILIL 200 MG/200 MG FİLM TABLET, 40 TABLETProducts: GAMAFLEX 400 MG FİLM KAPLI TABLET, 40 ADETBesifloxacin
go.drugbank.com/drugs/DB06771ApprovedBesifloxacin is a fourth generation fluoroquinolone-type opthalmic antibiotic for the treatment of bacterial conjunctivitis. FDA approved on May 28, 2009.
Categories: 4-Quinolones, Heterocyclic Compounds, 1-RingProducts: BESIVANCE % 0,6 OFTALMIK SÜSPANSIYON, 5 MLMetildigoxin
go.drugbank.com/drugs/DB13401InvestigationalCategories: Compounds used in a research, industrial, or household settingProducts: CARDIOX® 0.2 MG/2MLAMPOLLA, MYORITMO®Islatravir
go.drugbank.com/drugs/DB15653ApprovedInvestigational[A275492] On April 21, 2026, the FDA approved the first fixed-dose combination containing islatravir (0.25 mg) and the NNRTI doravirine (100 mg), marketed as IDVYNSO, as a complete once-daily regimen for … [A275492, L56138] Chemically, it is a deoxyadenosine analogue distinguished by a 4'-ethynyl group and a 2-fluoro substitution, which collectively enhance its metabolic stability and potency.
Synonyms: 4'-ethynyl-2-fluoro-2'-deoxyadenosineCategories: Heterocyclic Compounds, 2-RingProtein S100-A1
go.drugbank.com/bio_entities/BE0001090TargetHumansRegulates a network in cardiomyocytes controlling sarcoplasmic reticulum Ca(2+) cycling and mitochondrial function through interaction with the ryanodine receptors RYR1 and RYR2, sarcoplasmic reticulum … Facilitates diastolic Ca(2+) dissociation and myofilament mechanics in order to improve relaxation during diastole (PubMed:11717446)
Synonyms: S-100 protein alpha chain, S-100 protein subunit alphaTianeptine
go.drugbank.com/drugs/DB09289InvestigationalStructurally, it is classified as a tricyclic antidepressant (TCA), however, it possesses different pharmacological properties than typical tricyclic antidepressants [A31969]. … Tianeptine is a drug used primarily in the treatment of major depressive disorder and has been studied in the treatment of irritable bowel syndrome (IBS) [A31983].
Categories: Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 SubstratesProducts: STABLON TABLET 12.5 mg, STABLON 12.5 MG TABLET, 60 ADETBretylium
go.drugbank.com/drugs/DB01158ApprovedRecent evidence has shown that bretylium may also inhibit the Na,K-ATPase by binding to the extracellular K-site. … The primary mode of action for bretylium is thought to be inhibition of voltage-gated K(+) channels.
Mixtures: Bretylium Tosylate 0.4% and Dextrose 5% Inj, Bretylium Tosylate 0.2% and Dextrose 5% InjSynonyms: 2-bromo-N-ethyl-N,N-dimethylbenzenemethanaminium, N-ethyl-N,N-dimethyl-2-bromobenzenemethanaminium